This follows the initial licence for treatment of patients with non-metastatic castration-resistant prostate cancer (nmCRPC) in 2020. Following entry into a commercial agreement with Bayer ...

The associate medical director of University Hospitals of Northamptonshire (UHN), Chandran Tanabalan, said: "Focal therapy offers significant advantages over surgery and radiotherapy treatments as it ...

All men at high risk of prostate cancer should be offered checks even if it costs the NHS more to deliver it ... early improves the odds of successful treatment. The Daily Mail is campaigning ...

A groundbreaking procedure is offering new hope for men suffering from benign prostate hyperplasia (BPH), a condition ...

A doctor has urged men not to ignore a common nighttime habit as it could be a symptom of a deadly disease affecting the ...